Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2014-02-28
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The adhesion molecule Ninj1 is induced following nerve injury where it contributes to nerve generation. Besides it is described to facilitate leukocyte migration especially in the nervous system.
* The investigators hypothesize that Ninj1 expression is increased in SIRS patients, which will fortify its impact during inflammation and the transferability from bench to bedside.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
NCT06462768
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
NCT00853788
Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis
NCT03268330
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987
Plexin D1 as a Potential Biomarker inPM/DM
NCT05637931
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy
Healthy individuals no infection
No interventions assigned to this group
SIRS
SIRS patients no included in an interventional study no peroperative infection
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* cardiac surgery patients
Exclusion Criteria
* Preoperative Infection (e.g. Endocarditis)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Patrick Meybohm, M.D.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Patrick Meybohm, M.D.
PD Dr. Patrick Meybohm, M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Meybohm, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesiology, University Hospital Frankfurt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology, University Hospital Frankfurt
Frankfurt am Main, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NINJ1-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.